Search - tctmd.com

Displaying 121 - 140 of 825

Sort: Relevancy | Date

Lp(a) Still Low Almost 1 Year After Last Olpasiran Injection: OCEAN(a)-DOSE

News Daily News

Lp(a) Still Low Almost 1 Year After Last Olpasiran Injection: OCEAN(a)-DOSE

Yael L. Maxwell

August 19, 2024

Both SGLT2 and GLP-1 Drugs Help Heart and Kidneys in Type 2 Diabetes

News Daily News

Both SGLT2 and GLP-1 Drugs Help Heart and Kidneys in Type 2 Diabetes

Michael O'Riordan

August 19, 2024

CMS Announces Negotiated Medicare Prices for First 10 Drugs

News Daily News

CMS Announces Negotiated Medicare Prices for First 10 Drugs

Yael L. Maxwell

August 16, 2024

Only Small Minority of Eligible Patients Prescribed SGLT2 Inhibitors

News Daily News

Only Small Minority of Eligible Patients Prescribed SGLT2 Inhibitors

Yael L. Maxwell

August 15, 2024

Tirzepatide Provides Sustained BP Reduction in Overweight Adults

News Daily News

Tirzepatide Provides Sustained BP Reduction in Overweight Adults

August 15, 2024

Studies Highlight Rapid Growth of Semaglutide Use, Risks of Some Online Sources

News Daily News

Studies Highlight Rapid Growth of Semaglutide Use, Risks of Some Online Sources

August 12, 2024

Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question

News Features

Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question

August 09, 2024

Semaglutide May Ease Tobacco Use, Study Suggests

News Daily News

Semaglutide May Ease Tobacco Use, Study Suggests

August 01, 2024

SUMMIT Meets Primary Endpoint for Safety, Efficacy of Tirzepatide: Topline Results

News Daily News

SUMMIT Meets Primary Endpoint for Safety, Efficacy of Tirzepatide: Topline Results

Yael L. Maxwell

August 01, 2024

Schoolwide Intervention May Improve Obesity Outcomes Over Time

News Daily News

Schoolwide Intervention May Improve Obesity Outcomes Over Time

Yael L. Maxwell

July 29, 2024

Reduced Vascular Load, Better RV Function With Dapagliflozin in HFpEF

News Daily News

Reduced Vascular Load, Better RV Function With Dapagliflozin in HFpEF

Michael O'Riordan

July 26, 2024

Coronary Calcium Scoring May Help Get Semaglutide to Highest-Risk Patients

News Conference News SCCT 2024

Coronary Calcium Scoring May Help Get Semaglutide to Highest-Risk Patients

July 22, 2024

Constellations of Sleep Issues Can Point to Patients at Risk for AF

News Daily News

Constellations of Sleep Issues Can Point to Patients at Risk for AF

July 17, 2024

Real-world Patients Might Lose More Weight With Tirzepatide vs Semaglutide

News Daily News

Real-world Patients Might Lose More Weight With Tirzepatide vs Semaglutide

Yael L. Maxwell

July 10, 2024

Apixaban May Have Advantages in Patients With Liver Cirrhosis and AF

News Daily News

Apixaban May Have Advantages in Patients With Liver Cirrhosis and AF

Michael O'Riordan

July 09, 2024

LIBerate-HR: Lerodalcibep Lowers LDL More Sharply Than Placebo Over 1 Year

News Conference News ACC 2024

NOW PUBLISHED - LIBerate-HR: Lerodalcibep Lowers LDL More Sharply Than Placebo Over 1 Year

Yael L. Maxwell

July 03, 2024

‘Provocative’ Projections See Semaglutide Slashing CV Events in Adults With ASCVD

News Daily News

‘Provocative’ Projections See Semaglutide Slashing CV Events in Adults With ASCVD

June 27, 2024

Semaglutide Has Similar Benefits in Women and Men With HFpEF

News Daily News

Semaglutide Has Similar Benefits in Women and Men With HFpEF

June 26, 2024

Weight-Loss Drug Tirzepatide Reduces Severity of Obstructive Sleep Apnea

News Daily News

Weight-Loss Drug Tirzepatide Reduces Severity of Obstructive Sleep Apnea

Michael O'Riordan

June 25, 2024

The Hole Story: Interatrial Shunt Companies Are—Mostly—Pushing Ahead

News Daily News

The Hole Story: Interatrial Shunt Companies Are—Mostly—Pushing Ahead

Michael O'Riordan

June 20, 2024

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.